Clinical Trial Update: A Study of RoActemra/Actemra (Tocilizumab) in Combination With DMARDs Versus Current Best Practice DMARD Therapy in Patients With Rheumatoid Arthritis [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating tocilizumab (RoActemra/Actemra) in combination with DMARDs versus current best-practice DMARD therapy in rheumatoid arthritis; the stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• RoActemra/Actemra (tocilizumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Rheumatoid Arthritis | Phase 4 | Status: TERMINATED | Results posted: 2014-11-11